5-HTP: What the Evidence Says About Its Benefits and Risks
Among the supplements people use for mood, sleep, and overall well-being, 5-hydroxytryptophan (5-HTP) gets a lot of attention. It's made from the amino acid tryptophan, and the body turns it into serotonin, a neurotransmitter involved in mood, sleep, and appetite. This post looks at the science behind 5-HTP, reviews the studies, and spends real time on safety, because with 5-HTP the safety section matters as much as the benefits.
What Is 5-HTP?
Your body makes 5-HTP from tryptophan, an essential amino acid found in foods like turkey, eggs, and seeds, and then converts 5-HTP into serotonin. Serotonin itself can't cross the blood-brain barrier, so swallowing it wouldn't raise brain levels. 5-HTP can cross, which is why it's sold as a way to support serotonin. Supplements are usually extracted from the seeds of an African plant, Griffonia simplicifolia.
Two caveats. First, much of an oral dose is converted to serotonin outside the brain, in the gut and bloodstream, which is likely why nausea is its most common side effect and why many older trials paired it with carbidopa, a drug that blocks that conversion. Second, the idea that depression is simply a "serotonin deficiency" is shakier than it once seemed: a widely debated 2022 umbrella review found no consistent evidence that low serotonin causes depression. That doesn't mean serotonin-targeting treatments can't help, but "top up your serotonin" is an oversimplification.
5-HTP for Depression: A Natural Antidepressant?
Depression is the most researched use of 5-HTP, studied both as an alternative and as an add-on to antidepressants such as selective serotonin reuptake inhibitors (SSRIs).
A Cochrane review (Shaw et al., 2002) found 108 studies of 5-HTP and tryptophan for depression and judged only two, with 64 patients in total, good enough to include. Combined, the two supplements did better than placebo, but the authors called the evidence "of insufficient quality to be conclusive" and, because proven antidepressants exist, considered their clinical usefulness limited. A 2020 meta-analysis of 13 studies (Javelle et al.) found large average improvements, but few of the studies had placebo groups and the authors rated the research as relatively weak overall.
A more recent trial looked at Parkinson's disease, where depression is a common non-motor symptom. In a randomized, double-blind, placebo-controlled crossover study of 25 patients, 50 mg of 5-HTP daily for four weeks significantly reduced depressive symptoms on the Hamilton Depression Rating Scale compared with placebo (Meloni et al., 2020). It had no effect on apathy, which suggests it acted on mood rather than motivation or interest. The authors describe the finding as preliminary.
Turner, Loftis, and Blackwell (2006) reviewed the evidence for 5-HTP in depression. They found the supportive trials mostly small and old, and they devoted much of the review to two safety issues, serotonin syndrome and eosinophilia-myalgia syndrome. Turner's group has also proposed pairing 5-HTP with an SSRI, but that remains a hypothesis, and it's exactly the combination that risks serotonin syndrome.
5-HTP for Sleep
Serotonin is also the raw material for melatonin, the hormone that helps time the sleep cycle, which is why 5-HTP is often marketed as a natural sleep aid. A small 1971 sleep-lab study by Wyatt and colleagues found that 5-HTP increased REM sleep in healthy volunteers. REM sleep plays a role in memory and emotional regulation, but more REM in a lab isn't the same as better sleep for someone with insomnia, and the study is more than fifty years old. Newer evidence is narrow: a small open-label study in children with sleep terrors and a small trial in Parkinson's disease. None shows that 5-HTP treats insomnia in adults.
Weight Loss and Appetite Control
Because serotonin helps regulate appetite, 5-HTP has been studied for weight management. In a randomized, double-blind trial, Cangiano et al. (1992) gave 20 adults with obesity either 900 mg of 5-HTP a day or a placebo for 12 weeks, with a reduced-calorie diet recommended for the second six weeks. The 5-HTP group lost a significant amount of weight in both periods, ate fewer carbohydrates, and consistently reported feeling full early. The caveats: the trial was tiny, more than 30 years old, and used a dose several times higher than a typical capsule. There's no long-term data.
5-HTP and Anxiety
Serotonin pathways are involved in anxiety, and a 2016 review by Jenkins and colleagues describes how tryptophan and serotonin influence mood and cognition. That review covers the serotonin system broadly, though, not 5-HTP trials. Direct evidence is limited and old. In a 1987 double-blind trial of 45 people with anxiety disorders, 5-HTP produced a moderate reduction on some anxiety measures, while the antidepressant clomipramine outperformed it on all of them (Kahn et al.). In a 2002 lab study, a single 200 mg dose blunted the panic response to a carbon-dioxide challenge in people with panic disorder. 5-HTP is not a first-line treatment for anxiety; therapy and prescribed medication have far stronger evidence.
Safety Considerations and Side Effects
The most common side effects are digestive: nausea, stomach discomfort, and diarrhea, especially at higher doses. The serious risks are serotonin syndrome and a possible link to eosinophilia-myalgia syndrome.
Serotonin syndrome is caused by too much serotonin activity, usually when two or more serotonin-raising substances are combined. Symptoms include agitation, confusion, a racing heart, high blood pressure, sweating, tremor, muscle twitching or rigidity, and fever. Severe cases are a medical emergency and can be fatal (Boyer & Shannon, 2005).
Do not combine 5-HTP with any of these unless your prescriber specifically tells you to:
- Antidepressants: SSRIs, SNRIs, tricyclics, and especially MAO inhibitors, which carry the highest risk
- Migraine triptans (such as sumatriptan)
- Tramadol, meperidine, and dextromethorphan (in many cough syrups)
- Lithium, St. John's wort, or L-tryptophan
- Carbidopa (used in Parkinson's), which has been linked in case reports to a scleroderma-like illness when combined with 5-HTP
Its safety in pregnancy and breastfeeding hasn't been established, and in bipolar disorder anything that acts like an antidepressant can trigger mania.
Eosinophilia-myalgia syndrome (EMS) is a rare, serious condition involving severe muscle pain and a spike in certain white blood cells. In 1989, contaminated L-tryptophan from a single manufacturer caused an outbreak that sickened more than 1,500 Americans and killed dozens. 5-HTP has its own, much smaller history: in 1994, NIH researchers described a family who developed an EMS-like illness after taking 5-HTP containing an impurity (Michelson et al.), and a contaminant called "Peak X" was later identified and found at lower levels in several over-the-counter products (Klarskov et al., 2003). Industry-affiliated reviewers argue the concern is overstated. The link is rare and unresolved, not absent, which is one more reason to buy only products verified by an independent tester such as USP or NSF.
What Doses Have Studies Used?
There's no established dose of 5-HTP for any condition. Studies have used very different amounts: 50 mg a day in the Parkinson's trial, a single 200 mg dose in the panic study, and 900 mg a day in the weight-loss trial; many older depression trials used several hundred milligrams a day, often with carbidopa. Higher doses bring more side effects. If you and your doctor decide to try it, the usual approach is to start low, and never alongside a serotonergic medication without the prescriber's approval.
Conclusion: Is 5-HTP Right for You?
5-HTP is biologically plausible and has a handful of small, mostly older positive trials for depression and appetite. The sleep and anxiety claims run ahead of the data, and larger, well-controlled studies are needed to establish its long-term efficacy and safety. If you're dealing with depression, treatments with stronger evidence, such as psychotherapy, prescribed antidepressants, and exercise, are the place to start. If you're considering 5-HTP, talk with your healthcare provider first, especially if you take anything that affects serotonin.
This article is for educational purposes only and isn't medical advice. Don't start, stop, or combine supplements and medications on your own. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a mental health condition, or take any prescription medication (above all, antidepressants, migraine medications, or pain medications). If you have thoughts of harming yourself, call or text 988 in the U.S. or contact your local emergency services.
Key Sources
- Shaw K, Turner J, Del Mar C. Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database of Systematic Reviews, 2002. PubMed
- Javelle F, et al. Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis. Nutrition Reviews, 2020. PubMed
- Moncrieff J, et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry, 2022 (print 2023). PubMed
- Meloni M, Puligheddu M, Carta M, Cannas A, Figorilli M, Defazio G. Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding. European Journal of Neurology, 2020;27(5):779–786. PubMed
- Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacology & Therapeutics, 2006. PubMed
- Wyatt RJ, Zarcone V, Engelman K, Dement WC, Snyder F, Sjoerdsma A. Effects of 5-hydroxytryptophan on the sleep of normal human subjects. Electroencephalography and Clinical Neurophysiology, 1971. PubMed
- Cangiano C, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. American Journal of Clinical Nutrition, 1992. PubMed
- Kahn RS, et al. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. International Clinical Psychopharmacology, 1987. PubMed
- Boyer EW, Shannon M. The serotonin syndrome. New England Journal of Medicine, 2005. PubMed
- Klarskov K, et al. Structural characterization of a case-implicated contaminant, "Peak X," in commercial preparations of 5-hydroxytryptophan. Journal of Rheumatology, 2003. PubMed
Related Reading
- The Four Happiness Chemicals — where serotonin fits alongside dopamine, oxytocin, and endorphins
- Master Your Emotions — evidence-based tools for mood that don't come in a capsule
- Sleep and Longevity — what actually improves sleep, and why it matters
- How to Read Health Science — how to judge small, old, or uncontrolled studies like the ones above
- Creatine: Benefits, Side Effects, and What the Evidence Shows — a supplement with a much deeper evidence base
Supplements, Without the Hype
Get evidence-based wellness practices grounded in science, with the caveats included, delivered weekly.
Subscribe to the Newsletter